Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D05VBJ
|
|||
Drug Name |
Triazolo-pyridine derivative 4
|
|||
Synonyms |
PMID27321640-Compound-51
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
LUNDBECK & CO AS H [DK]
|
|||
Structure |
Download2D MOL |
|||
Formula |
C15H10ClN5
|
|||
Canonical SMILES |
CC1=NC2=C(C=NC=C2)N3C1=NN=C3C4=CC=CC=C4Cl
|
|||
InChI |
1S/C15H10ClN5/c1-9-14-19-20-15(10-4-2-3-5-11(10)16)21(14)13-8-17-7-6-12(13)18-9/h2-8H,1H3
|
|||
InChIKey |
SNQXTEAQGLZIDL-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Phosphodiesterase 10A (PDE10) | Target Info | Inhibitor | [1] |
Phosphodiesterase 2A (PDE2A) | Target Info | Inhibitor | [1] | |
Target's Patent Info | Phosphodiesterase 10A (PDE10) | Target's Patent Info | [1] | |
Phosphodiesterase 2A (PDE2A) | Target's Patent Info | [1] | ||
KEGG Pathway | Purine metabolism | |||
Morphine addiction | ||||
cGMP-PKG signaling pathway | ||||
NetPath Pathway | TSH Signaling Pathway | |||
Pathwhiz Pathway | Purine Metabolism | |||
Reactome | cGMP effects | |||
G alpha (s) signalling events |
References | Top | |||
---|---|---|---|---|
REF 1 | Towards selective phosphodiesterase 2A (PDE2A) inhibitors: a patent review (2010 - present).Expert Opin Ther Pat. 2016 Aug;26(8):933-46. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.